Dermatology
Latest News
Stop using Neutrogena and Aveeno spray sunscreen, J&J warns
Consumers should stop using these products and throw them away, the company said.
Latest News
Proposed classification framework for atopic dermatitis unveiled
“There are some patients who have milder-looking lesions, but their itch is just out of control. ... This is a pattern that we need to recognize...
From the Journals
Metformin use may curb BCC risk
Population-based study shows a potential protective effect of metformin use for basal cell carcinoma, but no effect on risk of squamous cell...
News
Latest FDA pembrolizumab approval expands label to cutaneous SCCs
The objective response rate in 54 patients with locally advanced disease was 50%, including a complete response rate of 17% and a partial response...
Conference Coverage
Patients on methotrexate show T-cell response to Pfizer vaccine
Despite poor antibody response to the mRNA COVID-19 vaccine, cellular immunity was generated in patients taking methotrexate, new research shows...
From the Journals
New analysis puts U.S. psoriasis prevalence at 3%
Data from national survey show that no significant change in prevalence has occurred since 2003.
Conference Coverage
Expert shares practical considerations when prescribing dupilumab
Real-world data suggests that the effectiveness of dupilumab is similar to the efficacy seen in clinical trials.
Conference Coverage
Baricitinib found effective for moderate to severe AD out to 52 weeks
At weeks 16, 32, and 52, the proportion of patients who achieved an EASI75 response was 40%, 51%, and 49%, respectively.
From the Journals
In Black patients, acne scarring might not mean what you think
They may use the term to refer to postinflammatory hyperpigmentation.
Latest News
Ruxolitinib cream for atopic dermatitis found to be effective, safe up to 52 weeks
Treatment-related adverse events were reported in 5% of patients who applied 0.75% ruxolitinib cream and in 3% of patients who applied 1.5%...
Latest News
Survey spotlights the out-of-pocket burden on Blacks with atopic dermatitis
The findings “provide another piece of evidence for increased financial burden among black individuals with AD and support the need for targeted...